Skip to content

Author

Yu-Feng Yuan

We have 2 of 9 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Guidance

HCC-STAR (Hepatocellular Carcinoma Staging, Treatment and pRognosis), a clinically aligned large language model that reads routine EMR narratives and jointly outputs risk score-based staging, ranked guideline-consistent treatments with evidence-based rationales, and individualized survival estimates, is presented.

Peng Cui, Ji-Tao Wang, Siyan Xue et al. · 0 citations
Open access Jul 2026

PDIA6 exacerbates hepatocellular carcinoma via enhancing proteasome-dependent degradation of AKAP12.

This study experimentally validated that PDIA6 promotes the proliferation and metastasis of HCC cells and uncovered the HCC-promoting mechanism of the PDIA6-AKAP12-Wnt signaling axis and highlights its great potential for the development of therapeutic targets in HCC.

Rucheng Yao, Yuhan Yin, Xiaosong Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.